학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 762건 | 목록 1~20
Academic Journal
Aoki T; Princess Margaret Cancer Centre Toronro, Ontario Canada.; Duns G; BC Cancer Agency Vancouver Canada.; Rai S; British Columbia Cancer Agency Vancouver Canada.; Jiang A; BC Cancer Agency Vancouver, BC Canada.; Lytle A; British Columbia Cancer Agency Vancouver Canada.; Yin Y; British Columbia Cancer Agency Vancouver Canada.; Kishida M; British Columbia Cancer Agency Vancouver Canada.; Yu Li M; British Columbia Cancer Agency Vancouver Canada.; Lee C; British Columbia Cancer Agency Vancouver Canada.; Smorra D; BC Cancer Agency Canada.; Hilton LK; BC Cancer Agency Vancouver, BC Canada.; Healy S; British Columbia Cancer Agency Vancouver Canada.; Alig SK; Stanford Medicine Stanford United States.; Shahrokh Esfahani M; Stanford University Stanford, CA United States.; Sarkozy C; Institut Curie, Saint Cloud, France Saint Cloud France.; Hung SS; BC Cancer Agency Vancouver, British Columbia Canada.; Milne K; British Columbia Cancer Agency Victoria, British Columbia Canada.; Telenius A; British Columbia Cancer Agency Vancouver, British Columbia Canada.; O Brien L; British Columbia Cancer Agency Vancouver Canada.; Wong JC; British Columbia Cancer Agency Vancouver Canada.; Cassidy C; British Columbia Cancer Agency Vancouver Canada.; Fujisawa M; British Columbia Cancer Agency Vancouver Canada.; Strong C; British Columbia Cancer Agency Victoria, British Columbia Canada.; Goodyear T; University of Limerick Limerick, Limerick Ireland.; Di Vito C; British Columbia Cancer Agency Victoria, British Columbia Canada.; Luksik C; British Columbia Cancer Agency Victoria, British Columbia Canada.; Edin G; British Columbia Cancer Agency Vancouver Canada.; Gonzalez L; British Columbia Cancer Agency Vancouver, BC Canada.; Rangel Patiño J; Princess Margaret Cancer Centre Canada.; Hong M; Princess Margaret Cancer Centre Ontario Canada.; Wu S; University of British Columbia Vancouver, BC Canada.; Lee E; University of British Columbia Vancouver, BC Canada.; Sakhdari A; University Health Network Toronto, ON Canada.; Takata K; University of Toyama Japan.; Miyata-Takata T; BC Cancer Agency Vancouver Canada.; Boyle M; BC Cancer Agency Vancouver, BC Canada.; Ben-Neriah S; British Columbia Cancer Agency Vancouver Canada.; Weng AP; BC Cancer Agency Vancouver, BC Canada.; Xu A; University of Maryland, College Park College Park, MA United States.; Merchant A; Cedars-Sinai Medical Center Los Angeles United States.; Roth A; University of British Columbia Vancouver, BC Canada.; Crump M; Princess Margaret Cancer Centre Toronto, Ontario Canada.; Kuruvilla J; Princess Margaret Cancer Centre Toronto Canada.; Prica A; Princess Margaret Cancer Centre Toronto Canada.; Kridel R; Princess Margaret Cancer Centre Toronto Canada.; Huntsman DG; University of British Columbia Vancouver, BC Canada.; Nelson BH; Institute Curie Victoria, BC Canada.; Farinha P; BC Cancer Agency Vancouver Canada.; Morin RD; Simon Fraser University Burnaby, British Columbia Canada.; Alizadeh AA; Stanford University Stanford, CA United States.; Savage KJ; British Columbia Cancer Agency vancouver, bc Canada.; Scott DW; British Columbia Cancer Agency Vancouver Canada.; Steidl C; British Columbia Cancer Agency Vancouver Canada.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Delaidelli A; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Burwag F; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer, Vancouver, British Columbia, Canada.; Suk Y; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.; Centre for Discovery in Cancer Research (CDCR), McMaster University, Hamilton, Ontario, Canada.; Shyp T; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.; Kosteniuk S; Department of Pathology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.; Dunham C; Department of Pathology and Laboratory Medicine, Children's and Women's Health Centre of British Columbia, and University of British Columbia, Vancouver, British Columbia, Canada.; Cheng S; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.; Okonechnikov K; Hopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schrimpf D; Department of Neuropathology of Heidelberg University and CCU Neuropathology, German Cancer Research Center, Heidelberg, Germany.; von Deimling A; Department of Neuropathology of Heidelberg University and CCU Neuropathology, German Cancer Research Center, Heidelberg, Germany.; Ellezam B; Division of Pathology, Department of Pathology and Cell Biology, CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.; Perreault S; Department of Neurosciences, Division of Child Neurology, CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada.; Singh S; Department of Surgery, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.; Centre for Discovery in Cancer Research (CDCR), McMaster University, Hamilton, Ontario, Canada.; Hawkins C; Division of Pathology, Hospital for Sick Children, Toronto, Ontario, Canada.; Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Kool M; University Medical Center Utrecht, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Research Consortium (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Pfister SM; Department of Pediatric Hematology and Oncology, University Hospital, and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Steidl C; Centre for Lymphoid Cancer, BC Cancer, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Hughes C; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.; Korshunov A; Department of Neuropathology of Heidelberg University and CCU Neuropathology, German Cancer Research Center, Heidelberg, Germany.; Sorensen PH; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Report
Kuruvilla J; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Rushton C; Simon Fraser University, Burnaby, British Columbia, Canada.; Villa D; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, British Columbia, Canada.; Aslam M; Hematology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Prica A; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Abdel Samad N; Hematology, The Moncton Hospital, Moncton, New Brunswick, Canada.; Doucet S; Hematologic Oncology, CHUM-Hopital Notre-Dame, Montreal, Quebec, Canada.; Dudebout J; Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada.; Fleury I; Hematologic Oncology, Maisonneuve Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada.; Fraser G; Hematology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.; Larouche JF; CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada.; Shafey M; Alberta Health Services, University of Calgary, Calgary, Alberta, Canada.; Skrabek P; Section of Hematology/Oncology Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.; Skamene T; Jewish General Hospital, Montreal, Quebec, Canada.; Morin RD; Simon Fraser University, Burnaby, British Columbia, Canada.; Alcaide M; Simon Fraser University, Burnaby, British Columbia, Canada.; Ben-Neriah S; BC Cancer Centre for Lymphoid Cancer, Vancouver, British Columbia, Canada.; Lee D; Department of Medicine, Queen's University, Kingston, Ontario, Canada.; Winch C; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Shepherd LE; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Scott DW; BC Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, British Columbia, Canada.; Crump M; Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Hay AE; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Academic Journal
Shelton V; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Detroja R; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Liu T; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Isaev K; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Silva A; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Vector Institute, Toronto, ON, Canada.; Passerini V; Department of Internal Medicine III, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany.; Bakhtiari M; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Calvente L; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Hong M; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; He MY; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Modi S; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Hershenfeld SA; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada.; Ludvigsen M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Madsen C; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Hamilton-Dutoit S; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.; d'Amore FA; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Brodtkorb M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Johnson NA; Jewish General Hospital, Montreal, QC, Canada.; Baetz T; Department of Oncology, Queen's University, Kingston, ON, Canada.; LeBrun D; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.; Tobin JWD; Mater Research University of Queensland, Brisbane, QLD, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Gandhi MK; Mater Research University of Queensland, Brisbane, QLD, Australia.; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Mungall AJ; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, BC, Canada.; Xu W; Department of Biostatistics, Princess Margaret Cancer Centre, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Ben-Neriah S; BC Cancer, Vancouver, BC, Canada.; Steidl C; BC Cancer, Vancouver, BC, Canada.; Delabie J; Laboratory and Medicine Program, University Health Network, Toronto, ON, Canada.; Tremblay-LeMay R; Laboratory and Medicine Program, University Health Network, Toronto, ON, Canada.; Jegede O; Dana Farber Cancer Institute, Boston, MA, USA.; Weigert O; Department of Internal Medicine III, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kahl B; Washington University, St. Louis, MO, USA.; Evens AM; Rutgers Cancer Institute, New Brunswick, NJ, USA.; Kridel R; Princess Margaret Cancer Centre-University Health Network, Toronto, ON, Canada. robert.kridel@uhn.ca.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Academic Journal
Rai S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan.; Duns G; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Frontzek F; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Wong JCH; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Yin Y; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Kishida M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Fujisawa M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Institute of Medicine, University of Tsukuba, Ibaraki, Japan.; Healy S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Viganò E; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Jiang A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Woolcock B; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Ben-Neriah S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Meissner B; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Boyle M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Nakamura H; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; O'Brien L; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Cassidy C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Lytle A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Farinha P; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Slack G; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Hilton LK; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Morin RD; Simon Fraser University, Burnaby, BC, Canada.; Venturutti L; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Aoki T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Princess Margaret Cancer Centre, Toronto, ON, Canada.; Wretham N; Department of Experimental Therapeutics, British Columbia Cancer Research Institute, Vancouver, BC, Canada.; Bush JW; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Evgin L; Michael Smith Genome Sciences Department, British Columbia Cancer Research Institute, Vancouver, BC, Canada.; Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.; Savage KJ; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.; Scott DW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.; Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Ben Neriah, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어